Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stachys lavandulifolia 1% gel versus diclofenac gel in primary monoarticular knee osteoarthritis
IRCT20190125042486N1Phase 2Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of diclofenac and celecoxib in knee osteoarthritis (OA) and osteoarthritis (OA) (3 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Pain reduction and Functional disability. Started Mar 2018; status: completed.
02
Drugs
diclofenaccelecoxib
03
Conditions
knee osteoarthritis (OA)osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20190125042486N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190125042486N1.